401 related articles for article (PubMed ID: 24550444)
1. IL-1 receptor blockade restores autophagy and reduces inflammation in chronic granulomatous disease in mice and in humans.
de Luca A; Smeekens SP; Casagrande A; Iannitti R; Conway KL; Gresnigt MS; Begun J; Plantinga TS; Joosten LA; van der Meer JW; Chamilos G; Netea MG; Xavier RJ; Dinarello CA; Romani L; van de Veerdonk FL
Proc Natl Acad Sci U S A; 2014 Mar; 111(9):3526-31. PubMed ID: 24550444
[TBL] [Abstract][Full Text] [Related]
2. Deficient autophagy unravels the ROS paradox in chronic granulomatous disease.
van de Veerdonk FL; Dinarello CA
Autophagy; 2014 Jun; 10(6):1141-2. PubMed ID: 24879159
[TBL] [Abstract][Full Text] [Related]
3. Inflammasome activation in NADPH oxidase defective mononuclear phagocytes from patients with chronic granulomatous disease.
Meissner F; Seger RA; Moshous D; Fischer A; Reichenbach J; Zychlinsky A
Blood; 2010 Sep; 116(9):1570-3. PubMed ID: 20495074
[TBL] [Abstract][Full Text] [Related]
4. Corticosteroids block autophagy protein recruitment in Aspergillus fumigatus phagosomes via targeting dectin-1/Syk kinase signaling.
Kyrmizi I; Gresnigt MS; Akoumianaki T; Samonis G; Sidiropoulos P; Boumpas D; Netea MG; van de Veerdonk FL; Kontoyiannis DP; Chamilos G
J Immunol; 2013 Aug; 191(3):1287-99. PubMed ID: 23817424
[TBL] [Abstract][Full Text] [Related]
5. Mammalian target of rapamycin inhibition counterbalances the inflammatory status of immune cells in patients with chronic granulomatous disease.
Gabrion A; Hmitou I; Moshous D; Neven B; Lefèvre-Utile A; Diana JS; Suarez F; Picard C; Blanche S; Fischer A; Cavazzana M; Touzot F
J Allergy Clin Immunol; 2017 May; 139(5):1641-1649.e6. PubMed ID: 27702670
[TBL] [Abstract][Full Text] [Related]
6. Chronic granulomatous disease: a potentially lethal combination of immunodeficiency and excess inflammation.
Clin Infect Dis; 2014 Jul; 59(2):iii. PubMed ID: 25105187
[No Abstract] [Full Text] [Related]
7. Reactive oxygen species-independent activation of the IL-1beta inflammasome in cells from patients with chronic granulomatous disease.
van de Veerdonk FL; Smeekens SP; Joosten LA; Kullberg BJ; Dinarello CA; van der Meer JW; Netea MG
Proc Natl Acad Sci U S A; 2010 Feb; 107(7):3030-3. PubMed ID: 20133696
[TBL] [Abstract][Full Text] [Related]
8. Treatment With Anakinra, a Recombinant IL-1 Receptor Antagonist, Unlikely to Induce Lasting Remission in Patients With CGD Colitis.
Hahn KJ; Ho N; Yockey L; Kreuzberg S; Daub J; Rump A; Marciano BE; Quezado M; Malech HL; Holland SM; Heller T; Zerbe CS
Am J Gastroenterol; 2015 Jun; 110(6):938-9. PubMed ID: 26052777
[No Abstract] [Full Text] [Related]
9. Robust T cell responses to aspergillosis in chronic granulomatous disease: implications for immunotherapy.
Cruz CR; Lam S; Hanley PJ; Bear AS; Langston C; Cohen AJ; Liu H; Martinez CA; Krance RA; Heslop HE; Rooney CM; Hanson IC; Bollard CM
Clin Exp Immunol; 2013 Oct; 174(1):89-96. PubMed ID: 23763437
[TBL] [Abstract][Full Text] [Related]
10. Olfm4 deletion enhances defense against Staphylococcus aureus in chronic granulomatous disease.
Liu W; Yan M; Sugui JA; Li H; Xu C; Joo J; Kwon-Chung KJ; Coleman WG; Rodgers GP
J Clin Invest; 2013 Sep; 123(9):3751-5. PubMed ID: 23908114
[TBL] [Abstract][Full Text] [Related]
11. Absence of respiratory burst in X-linked chronic granulomatous disease mice leads to abnormalities in both host defense and inflammatory response to Aspergillus fumigatus.
Morgenstern DE; Gifford MA; Li LL; Doerschuk CM; Dinauer MC
J Exp Med; 1997 Jan; 185(2):207-18. PubMed ID: 9016870
[TBL] [Abstract][Full Text] [Related]
12. Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease.
Romani L; Fallarino F; De Luca A; Montagnoli C; D'Angelo C; Zelante T; Vacca C; Bistoni F; Fioretti MC; Grohmann U; Segal BH; Puccetti P
Nature; 2008 Jan; 451(7175):211-5. PubMed ID: 18185592
[TBL] [Abstract][Full Text] [Related]
13. Exogenous Stimulation of Type I Interferon Protects Mice with Chronic Granulomatous Disease from Aspergillosis through Early Recruitment of Host-Protective Neutrophils into the Lung.
Seyedmousavi S; Davis MJ; Sugui JA; Pinkhasov T; Moyer S; Salazar AM; Chang YC; Kwon-Chung KJ
mBio; 2018 Mar; 9(2):. PubMed ID: 29588403
[TBL] [Abstract][Full Text] [Related]
14. Retroviral-mediated gene transfer of gp91phox into bone marrow cells rescues defect in host defense against Aspergillus fumigatus in murine X-linked chronic granulomatous disease.
Björgvinsdóttir H; Ding C; Pech N; Gifford MA; Li LL; Dinauer MC
Blood; 1997 Jan; 89(1):41-8. PubMed ID: 8978275
[TBL] [Abstract][Full Text] [Related]
15. CD4(+) T cell vaccination overcomes defective cross-presentation of fungal antigens in a mouse model of chronic granulomatous disease.
De Luca A; Iannitti RG; Bozza S; Beau R; Casagrande A; D'Angelo C; Moretti S; Cunha C; Giovannini G; Massi-Benedetti C; Carvalho A; Boon L; Latgé JP; Romani L
J Clin Invest; 2012 May; 122(5):1816-31. PubMed ID: 22523066
[TBL] [Abstract][Full Text] [Related]
16. Detailed characterisation of invasive aspergillosis in a murine model of X-linked chronic granulomatous disease shows new insights in infections caused by
King J; Dambuza IM; Reid DM; Yuecel R; Brown GD; Warris A
Front Cell Infect Microbiol; 2023; 13():1241770. PubMed ID: 37724291
[TBL] [Abstract][Full Text] [Related]
17. Impaired apoptotic cell clearance in CGD due to altered macrophage programming is reversed by phosphatidylserine-dependent production of IL-4.
Fernandez-Boyanapalli RF; Frasch SC; McPhillips K; Vandivier RW; Harry BL; Riches DW; Henson PM; Bratton DL
Blood; 2009 Feb; 113(9):2047-55. PubMed ID: 18952895
[TBL] [Abstract][Full Text] [Related]
18. PPARγ activation normalizes resolution of acute sterile inflammation in murine chronic granulomatous disease.
Fernandez-Boyanapalli R; Frasch SC; Riches DW; Vandivier RW; Henson PM; Bratton DL
Blood; 2010 Nov; 116(22):4512-22. PubMed ID: 20693431
[TBL] [Abstract][Full Text] [Related]
19. Chloroquine modulates the fungal immune response in phagocytic cells from patients with chronic granulomatous disease.
Henriet SS; Jans J; Simonetti E; Kwon-Chung KJ; Rijs AJ; Hermans PW; Holland SM; de Jonge MI; Warris A
J Infect Dis; 2013 Jun; 207(12):1932-9. PubMed ID: 23482646
[TBL] [Abstract][Full Text] [Related]
20. Anakinra Activates Superoxide Dismutase 2 to Mitigate Inflammasome Activity.
Pariano M; Pieroni S; De Luca A; Iannitti RG; Borghi M; Puccetti M; Giovagnoli S; Renga G; D'Onofrio F; Bellet MM; Stincardini C; Della-Fazia MA; Servillo G; van de Veerdonk FL; Costantini C; Romani L
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
